Literature DB >> 20437250

A case of polymyositis and vasculitis induced by ovulation induction therapy with gonadotropin-releasing hormone.

Ivica Lazúrová1, Jana Angelovicová, Jana Petríková, Anna Calfová, Mária Oetterová, Marián Svajdler.   

Abstract

Gonadotropin-releasing hormone (GnRH) is the first key hormone of reproduction. GnRH analogs are extensively used in in vitro fertilization and treatment of sex hormone-dependent cancers due to their ability to bring about 'chemical castration'. Recently it has been showed that it also plays an important role in the modulation of the immune system. We report a case of vasculitis and histologically proven severe polymyositis developed 5 days after GnRH administration due to ovulation induction in an infertile patient with no previous history of autoimmune diseases. After treatment with corticosteroids (prednisone, 30 mg daily), aspirin, and pentoxyphyllin in combination with rehabilitation, an amelioration of muscle impairment was observed.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20437250     DOI： 10.1007/s10067-010-1426-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


  17 in total

1.  Leuprolide acetate-induced leukocytoclastic vasculitis.

Authors:  Bengu Gerceker Turk; Tugrul Dereli; Didem Dereli; Taner Akalin
Journal:  Acta Obstet Gynecol Scand       Date:  2007       Impact factor: 3.636

2.  Luteinizing hormone-releasing hormone signaling at the lymphocyte involves stimulation of interleukin-2 receptor expression.

Authors:  N Batticane; M C Morale; F Gallo; Z Farinella; B Marchetti
Journal:  Endocrinology       Date:  1991-07       Impact factor: 4.736

3.  Worsening of systemic lupus erythematosus-associated thrombocytopenia after administration of gonadotropin-releasing hormone analog.

Authors:  S Miyagawa; T Shirai; I Shimamoto; M Ichijo; H Ueki
Journal:  Arthritis Rheum       Date:  1994-11

4.  Prevention of gonadal toxicity and preservation of gonadal function and fertility in young women with systemic lupus erythematosus treated by cyclophosphamide: the PREGO-Study.

Authors:  Karin Manger; Ludwig Wildt; Joachim R Kalden; Bernhard Manger
Journal:  Autoimmun Rev       Date:  2005-10-27       Impact factor: 9.754

5.  Neonatal treatment with luteinizing hormone-releasing hormone analogs alters peripheral lymphocyte subsets and cellular and humorally mediated immune responses in juvenile and adult male monkeys.

Authors:  D R Mann; A A Ansari; M A Akinbami; K Wallen; K G Gould; H M McClure
Journal:  J Clin Endocrinol Metab       Date:  1994-02       Impact factor: 5.958

6.  Allergic vasculitis induced by Decapeptyl: confirmation by macrophage migration inhibition factor (MIF) test.

Authors:  B Amichai; M H Grunwald; S Halevy
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  1993-12-30       Impact factor: 2.435

Review 7.  Drug-induced autoimmunity.

Authors:  Nancy J Olsen
Journal:  Best Pract Res Clin Rheumatol       Date:  2004-10       Impact factor: 4.098

8.  Expression of luteinizing hormone-releasing hormone and its receptor in porcine immune tissues.

Authors:  G D Weesner; B A Becker; R L Matteri
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

Review 9.  The hypothalamic-pituitary-gonadal axis: immune function and autoimmunity.

Authors:  F Tanriverdi; L F G Silveira; G S MacColl; P M G Bouloux
Journal:  J Endocrinol       Date:  2003-03       Impact factor: 4.286

10.  Importance of planning ovulation induction therapy in systemic lupus erythematosus and antiphospholipid syndrome: a single center retrospective study of 21 cases and 114 cycles.

Authors:  Du Le Thi Huong; Bertrand Wechsler; Danièle Vauthier-Brouzes; Pierre Duhaut; Nathalie Costedoat; Gilles Lefebvre; Jean-Charles Piette
Journal:  Semin Arthritis Rheum       Date:  2002-12       Impact factor: 5.532
View more
  3 in total

Review 1.  Ovarian stimulation and embryo banking for fertility preservation in a woman with severe mixed connective tissue disease: Is it safe?

Authors:  Vasileios D Sioulas; Clarisa R Gracia
Journal:  J Assist Reprod Genet       Date:  2011-12-29       Impact factor: 3.412

2.  Estrogen Downregulates miR-21 Expression and Induces Inflammatory Infiltration of Macrophages in Polymyositis: Role of CXCL10.

Authors:  Wang Yan; Caijing Chen; Huimin Chen
Journal:  Mol Neurobiol       Date:  2016-02-12       Impact factor: 5.590

3.  Short-term treatment with a gonadotropin-releasing hormone antagonist, cetrorelix, in rheumatoid arthritis (AGRA): a randomized, double-blind, placebo-controlled study.

Authors:  A S Kåss; O T Førre; M W Fagerland; H C Gulseth; P A Torjesen; I Hollan
Journal:  Scand J Rheumatol       Date:  2013-11-01       Impact factor: 3.641
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.